False positive images in the follow-up of patients with brain tumors
β Scribed by Moghrabi, Albert; Tien, Robert; Fuchs, Herbert; Longee, Darell; McLendon, Roger; Friedman, Henry S.
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 131 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
In recent years, major advances in the diagno-new enhancing lesions on MRI following treatsis and treatment of patients with brain tumors ment of their tumors with surgery (3 patients), have been seen. Today, evaluation of the central chemotherapy (2 patients), and radiotherapy (2 nervous system almost always includes mag-patients). Two patients underwent resection of netic resonance imaging (MRI). The appearance the lesion revealing gliosis. One patient had seof a new lesion on the MRI scan of a patient rial imaging that showed disappearance of the previously treated for a central nervous system lesions. (CNS) tumor raises concern for recurrent disease This suggests that not all new enhancing lewith the need for selection of new, potentially sions in previously treated brain tumor patients toxic therapy. However, the sensitivity of MRI represent tumor. Histologic proof of a suspicious may allow demonstration of new lesions which lesion should be demonstrated prior to initiation are not due to tumor. We now report three pa-of new therapy. Med.
π SIMILAR VOLUMES
Many screening methods are available for detecting diabetic retinopathy. However, once patients develop retinopathy, it is unclear as to what method should be used for their review. We describe a novel and integrated system for the screening and treatment of diabetic retinopathy using high street op
Neuroendocrine (NE) differentiation of prostatic adenocarcinomas has received increasing attention in recent years as a result of possible implications on prognosis and therapy. The incidence of NE cells in tumors has been reported from 10% up to 100%. Several studies have shown chromogranin A (CgA)
Patients with an history of carcinoma of the upper aerodigestive tract are at high risk for recurrence or the development of new tumors in this region. In the majority of follow-up protocols, these patients undergo radiologic and endoscopic evaluation as a means of surveillance for the early detecti